Advertisement
News
Advertisement

FDA OKs eNeura's novel migraine pain treatment stim

Tue, 12/17/2013 - 9:29am
Mass Device

California-based eNeura lands FDA clearance for its Cerena transcranial magnetic stimulator for treatment of migraines, passing through the FDA's less-stringent de novo review pathway.

FDA allows marketing for eNeura's migraine device

Medtech maker eNeura Therapeutics won FDA clearance to market its 1st-of-its-kind Cerena transcranial magnetic stimulator, landing regulatory approval through the agency's less-stringent de novo premarket review pathway.

The Cerena TMS is now the 1st available device to relieve migraine headache pain caused by auras, eNeura said.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading